1. Home
  2. GAIA vs XBIT Comparison

GAIA vs XBIT Comparison

Compare GAIA & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$2.08

Market Cap

70.9M

ML Signal

HOLD

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.30

Market Cap

74.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
XBIT
Founded
1988
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
74.4M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
GAIA
XBIT
Price
$2.08
$2.30
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.50
N/A
AVG Volume (30 Days)
290.8K
26.0K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
N/A
N/A
Revenue
$4,500,000.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$12.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.50
N/A
52 Week Low
$2.03
$2.09
52 Week High
$6.39
$3.61

Technical Indicators

Market Signals
Indicator
GAIA
XBIT
Relative Strength Index (RSI) 36.13 36.07
Support Level N/A $2.26
Resistance Level $2.68 $2.67
Average True Range (ATR) 0.15 0.04
MACD -0.03 -0.00
Stochastic Oscillator 8.24 0.00

Price Performance

Historical Comparison
GAIA
XBIT

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: